|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: paroxetine hydrochloride
| |||||||||||||||||||||
Clinical Trials for: paroxetine hydrochlorideRepeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects Status: Completed Condition: Depressive Disorder; Healthy Volunteer Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement Status: Recruiting Condition: Major Depression Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions Status: Completed Condition: Healthy Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions Status: Completed Condition: Healthy Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD) Status: Terminated Condition: Post-Traumatic Stress Disorder Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study) Status: Completed Condition: Major Depressive Disorder; Depressive Disorder Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg Status: Completed Condition: Healthy Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg Status: Completed Condition: Healthy Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study) Status: Completed Condition: Depressive Disorder; Major Depressive Disorder (MDD) Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg Status: Completed Condition: Healthy Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | PAXIL | paroxetine hydrochloride | CAPSULE; ORAL | 020885 | Oct 9, 1998 | DISCN | No | 6,172,233*PED | Y | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glaxosmithkline | PAXIL | paroxetine hydrochloride | CAPSULE; ORAL | 020885 | Oct 9, 1998 | DISCN | No | 6,133,289*PED | Y | <disabled> | DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, PANIC DISORDER AND SOCIAL ANXIETY DISORDER | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glaxosmithkline | PAXIL | paroxetine hydrochloride | CAPSULE; ORAL | 020885 | Oct 9, 1998 | DISCN | No | 6,121,291*PED | Y | <disabled> | POSTTRAUMATIC STRESS DISORDER | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glaxosmithkline | PAXIL | paroxetine hydrochloride | CAPSULE; ORAL | 020885 | Oct 9, 1998 | DISCN | No | 6,121,291*PED | Y | <disabled> | DEPRESSION | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc
